Document is current
Any future updates will be listed below
-
Authors
Xu, Ziyang http://orcid.org/0000-0001-7690-7029
Walker, Susanne
Wise, Megan C.
Chokkalingam, Neethu
Purwar, Mansi
Moore, Alan
Tello-Ruiz, Edgar
Wu, Yuanhan http://orcid.org/0000-0002-4706-439X
Majumdar, Sonali
Konrath, Kylie M. http://orcid.org/0000-0001-5222-782X
Kulkarni, Abhijeet
Tursi, Nicholas J. http://orcid.org/0000-0001-6752-3402
Zaidi, Faraz I.
Reuschel, Emma L. http://orcid.org/0000-0002-4627-1354
Patel, Ishaan
Obeirne, April
Du, Jianqiu
Schultheis, Katherine http://orcid.org/0000-0001-9232-1888
Gites, Lauren
Smith, Trevor
Mendoza, Janess
Broderick, Kate E.
Humeau, Laurent
Pallesen, Jesper http://orcid.org/0000-0002-3270-1587
Weiner, David B. http://orcid.org/0000-0002-2232-8512
Kulp, Daniel W. http://orcid.org/0000-0002-0527-3804
-
Funding
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (AI158777)
- License Information
-
More Information
Article History
Received: 24 February 2021
Accepted: 11 January 2022
First Online: 4 February 2022
Competing interests
: M.C.W., D.B.W., and D.W.K. have a pending patent about in vivo assembly of trimers using DNA delivery. M.C.W., K.E.B., and L.M.H. are employees of Inovio Pharmaceuticals and as such receive salary and benefits including ownership of stock and stock options from the company. D.B.W. has received grant funding, participates in industry collaborations, has received speaking honoraria, and has received fees for consulting, including serving on scientific review committees and board series. Remuneration received by D.B.W. includes direct payments, stock or stock options, and in the interest of disclosure he notes potential conflicts associated with his work with Inovio and possible others.
